Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Cells|May 6, 2020
Targeting GSK3 and Associated Signaling Pathways Involved in CancerPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Oncotarget|July 7, 2011
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapyMelissa L Sokolosky, Kristin M Stadelman, William H Chappell, et al.
Medical Oncology (Northwood, London, England)|July 21, 2025
Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategiesKomal Imran, Muhammad Javed Iqbal, Muhammad Mushtaq Ahmed, et al.
Scientific Reports|September 5, 2024
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosisSimona D'Aprile, Simona Denaro, Alessandro Lavoro, et al.
Advances in Biological Regulation|December 6, 2021
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53Stephen L Abrams, Shaw M Akula, Linda S Steelman, et al.
Methods and Protocols|October 28, 2025
Antidepressant and Related Neurobiological and Neurophysiological Effects of Add-On Transcranial Direct Current Stimulation in Major Depressive Disorder with Residual Symptoms: A Randomized, Double-Blind Clinical Trial ProtocolCarmen Concerto, Fabrizio Bella, Cecilia Chiarenza, et al.
International Journal of Molecular Medicine|February 9, 2006
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descentAngelo B Cefalù, Giacoma Barraco, Davide Noto, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2011
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cellsLinda S Steelman, Patrick Navolanic, William H Chappell, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Cells|May 6, 2020
Targeting GSK3 and Associated Signaling Pathways Involved in CancerPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Oncotarget|July 7, 2011
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapyMelissa L Sokolosky, Kristin M Stadelman, William H Chappell, et al.
Medical Oncology (Northwood, London, England)|July 21, 2025
Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategiesKomal Imran, Muhammad Javed Iqbal, Muhammad Mushtaq Ahmed, et al.
Scientific Reports|September 5, 2024
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosisSimona D'Aprile, Simona Denaro, Alessandro Lavoro, et al.
Advances in Biological Regulation|December 6, 2021
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53Stephen L Abrams, Shaw M Akula, Linda S Steelman, et al.
Methods and Protocols|October 28, 2025
Antidepressant and Related Neurobiological and Neurophysiological Effects of Add-On Transcranial Direct Current Stimulation in Major Depressive Disorder with Residual Symptoms: A Randomized, Double-Blind Clinical Trial ProtocolCarmen Concerto, Fabrizio Bella, Cecilia Chiarenza, et al.
International Journal of Molecular Medicine|February 9, 2006
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descentAngelo B Cefalù, Giacoma Barraco, Davide Noto, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2011
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cellsLinda S Steelman, Patrick Navolanic, William H Chappell, et al.
Pageof 28